Increasing burden of liver disease in patients with HIV infection.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  The Lancet

• Publication date

  2011-04-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(10)62001-6PMID 21459211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV‐coinfected patients

  2011cited by this paper
• Risk factors for advanced liver fibrosis in HIV‐infected individuals: role of antiretroviral drugs and insulin resistance

  2011cited by this paper
• MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

  2010cited by this paper
• Survival of HIV-infected patients with compensated liver cirrhosis

  2010cited by this paper
• Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

  2010cited by this paper
• British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010

  2010cited by this paper
• Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

  2010cited by this paper
• High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

  2010cited by this paper
• Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

  2010cited by this paper
• Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.

  2010cited by this paper
• Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

  2010cited by this paper
• Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

  2009cited by this paper
• Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

  2009cited by this paper
• gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis

  2009cited by this paper
• Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons

  2009cited by this paper
• Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs

  2009cited by this paper
• EASL Clinical Practice Guidelines: management of chronic hepatitis B.

  2009cited by this paper
• Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.

  2009cited by this paper
• Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

  2009cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

  2009cited by this paper
• Hepatitis B and long-term HIV outcomes in coinfected HAART recipients

  2009cited by this paper
• Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

  2009cited by this paper
• Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV‐infected clinical cohort

  2009cited by this paper
• Surveillance for acute viral hepatitis - United States, 2007.

  2009cited by this paper
• Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus‐1 mono‐infected patients on antiretroviral therapy

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

  2009cited by this paper
• Surveillance for acute viral hepatitis--United States, 2006.

  2008cited by this paper
• Recommendations for postexposure interventions to prevent infection with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus, and tetanus in persons wounded during bombings and other mass-casualty events--United States, 2008: recommendations of the Centers for Disease Control and P

  2008cited by this paper
• LIVER TRANSPLANTATION FOR HIV: ANALYSIS OF OUTCOMES SUGGEST HIV/HCV CO-INFECTED PATIENTS HAVE PROHIBITIVELY POOR SURVIVAL AT 5 YEARS

  2008cited by this paper
• Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

  2008cited by this paper
• Impact of Human Immunodeficiency Virus on Survival After Liver Transplantation: Analysis of United Network for Organ Sharing Database

  2008cited by this paper
• Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

  2008cited by this paper
• Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.

  2008cited by this paper
• Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.

  2008cited by this paper
• Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom.

  2008cited by this paper
• HIV increases HCV replication in a TGF-beta1-dependent manner.

  2008cited by this paper
• Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

  2007cited by this paper
• GI Epidemiology: nonalcoholic fatty liver disease

  2007cited by this paper
• Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?

  2007cited by this paper
• HIV-Positive Patients With Nonalcoholic Fatty Liver Disease Have a Lower Body Mass Index and Are More Physically Active Than HIV-Negative Patients

  2007cited by this paper
• Long-Term Body Composition and Metabolic Changes in Antiretroviral Naive Persons Randomized to Protease Inhibitor-, Nonnucleoside Reverse Transcriptase Inhibitor-, or Protease Inhibitor Plus Nonnucleoside Reverse Transcriptase Inhibitor-Based Strategy

  2007cited by this paper
• The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

  2007cited by this paper
• The model for end‐stage liver disease (MELD)

  2007cited by this paper
• Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients

  2007cited by this paper
• Hepatoportal Sclerosis as a Cause of Noncirrhotic Portal Hypertension in Patients With HIV

  2007cited by this paper
• Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.

  2007cited by this paper
• Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours

  2007cited by this paper
• Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count

  2007cited by this paper
• Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

  2007cited by this paper
• Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study) *

  2007cited by this paper
• Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.

  2007cited by this paper
• Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

  2007cited by this paper
• Viral hepatitis in HIV infection.

  2007cited by this paper
• Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy

  2007cited by this paper
• Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade

  2006cited by this paper
• Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C

  2006cited by this paper
• Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

  2006cited by this paper
• Intrahepatic cytokine expression is downregulated during HCV/HIV co‐infection

  2006cited by this paper
• Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

  2006cited by this paper
• Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127

  2006cited by this paper
• Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack of Suppression in HIV Infection

  2006cited by this paper
• Predictors of Antiretroviral-Related Hepatotoxicity in the Adult AIDS Clinical Trial Group (1989-1999)

  2006cited by this paper
• AIDS Res Hum Retroviruses

  2006cited by this paper
• Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

  2006cited by this paper
• Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation

  2006cited by this paper
• Prevalence of Risk Factors for Hepatitis C Virus in HIV-Infected and HIV/Hepatitis C Virus-Coinfected Patients

  2006cited by this paper
• Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients

  2006cited by this paper
• Viral kinetics and early prediction of nonresponse to peg‐IFN‐α‐2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus *

  2006cited by this paper
• Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.

  2006cited by this paper
• Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.

  2006cited by this paper
• Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

  2005cited by this paper
• Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

  2005cited by this paper
• Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis.

  2005cited by this paper
• Open, Randomized, Multicentre Italian Trial on Peg-Ifn plus Ribavirin versus Peg-Ifn Monotherapy for Chronic Hepatitis C in HIV-Coinfected Patients on Haart

  2005cited by this paper
• A cluster of acute hepatitis C virus infection among men who have sex with men – results from contact tracing and public health implications

  2005cited by this paper
• Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

  2005cited by this paper
• Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.

  2005cited by this paper
• HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis

  2005cited by this paper
• Guidelines for liver transplantation in patients with HIV infection (2005)

  2005cited by this paper
• Incidence and Risk Factors for Mitochondrial Toxicity in Treated HIV/HCV-Coinfected Patients

  2005cited by this paper
• Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.

  2005cited by this paper
• Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

  2005cited by this paper
• Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

  2004cited by this paper
• Comparison of HCV‐specific intrahepatic CD4+ T cells in HIV/HCV versus HCV

  2004cited by this paper
• Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors.

  2004cited by this paper
• Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.

  2004cited by this paper
• Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome

  2004cited by this paper
• Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

  2004cited by this paper
• Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

  2004cited by this paper
• Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy

  2004cited by this paper
• Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

  2004cited by this paper
• CD4 Cell Response to 3 Doses of Subcutaneous Interleukin 2: Metaanalysis of 3 Vanguard Studies

  2004cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Survival of human immunodeficiency virus-infected liver transplant recipients.

  2003cited by this paper
• Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients

  2003cited by this paper
• Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV.

  2003cited by this paper
• Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects.

  2003cited by this paper
• HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.

  2002cited by this paper

• Hepatocellular carcinoma in people living with HIV.

  2025cites this paper
• Advances in the management of hepatitis B

  2025cites this paper
• Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study

  2025cites this paper
• Presentation, treatment and long-term outcomes of hepatocellular carcinoma in patients with and without HIV: a comparative observational cohort study.

  2025cites this paper
• Integrated Assessment of Liver Disease Severity and Viral Load in Human Immunodeficiency Virus–Hepatitis B Virus Coinfected Individuals: Utilizing Aspartate Aminotransferase/Platelet Ratio Index and FIB-4 Biomarkers Alongside Real-time Polymerase Chain Reaction and Gene-specific Amplification Techni

  2025cites this paper
• Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV?

  2025cites this paper
• Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets

  2025cites this paper
• Neuropsychiatric and laboratory outcomes of hepatitis C treatment in an early-treated HIV cohort in Thailand

  2025cites this paper
• The rules in co-infection of multiple viruses across diverse lineages in a fungal host

  2025cites this paper
• Prevalence and Risk Factors of Hepatitis B and C Virus Co-Infection among Women Attending Antiretroviral Therapy Clinic in Yola, Nigeria

  2024cites this paper
• Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study

  2024cites this paper
• Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections

  2024cites this paper
• SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In Vivo

  2024cites this paper
• Steatotic liver disease and HIV: an agenda for 2030.

  2024cites this paper
• The Impact of Antiretroviral Therapy on Liver Function Among Pregnant Women Living with HIV in Co-Existence with and Without Pre-Eclampsia

  2024cites this paper
• A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs.

  2024cites this paper
• The clinical prognostic risk stratification system for HIV infected hepatocellular carcinoma.

  2024cites this paper
• Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study

  2024cites this paper
• Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV

  2024cites this paper
• Neuropsychiatric and Laboratory Outcomes of Hepatitis C Treatment in an Early-Treated HIV Cohort in Thailand

  2024cites this paper
• HIV-Infected Hepatic Stellate Cells or HCV-Infected Hepatocytes Are Unable to Promote Latency Reversal among HIV-Infected Mononuclear Cells

  2024cites this paper
• Chronic and Latent Viral Infections and Leukocyte Telomere Length across the Lifespan of Female and Male Individuals Living with or without HIV

  2024cites this paper
• Hepatitis C co-infection characteristics and correlates in newly reported HIV/AIDS patients in Southwest China, 2018–2022

  2023cites this paper
• Liver Transplantation in People Living with HIV: Still an Experimental Procedure or Standard of Care?

  2023cites this paper
• Letter: Rethinking the lower incidence of HCC in HIV‐infected patients— A closer look at confounding factors

  2023cites this paper
• Hépatites Delta en Afrique: particularités épidémiologiques et cliniques

  2023cites this paper
• Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy

  2023cites this paper
• Clinical features of Talaromyces marneffei infection in HIV-positive and HIV-negative individuals: a retrospective study in southern China.

  2023cites this paper
• Associated Factors and Immune Response to the Hepatitis B Vaccine with a Standard Schedule: A Prospective Study of People with HIV in China

  2023influential citation
• A Cross-Sectional Survey on the Post-Pandemic Acceptability of Pharmacist-Delivered Telehealth Services Among HCV-HIV Patients

  2023cites this paper
• Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study

  2023cites this paper
• Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus

  2023cites this paper
• Resting state network connectivity alterations in HIV: Parallels with aging

  2023cites this paper
• Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV

  2023cites this paper
• Explaining COVID-19 related mortality disparities in American Indians and Alaska Natives

  2023cites this paper
• Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States

  2023cites this paper
• Malignancy and viral infections in Sub-Saharan Africa: A review

  2023cites this paper
• CD4/CD8 Ratio Recovered as a Predictor of Decreased Liver Damage in Adults Infected With HIV: 16-Year Observational Cohort Study

  2023cites this paper
• Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy

  2023cites this paper
• Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens

  2023cites this paper
• The Correlated Risk Factors for Severe Liver Damage Among HIV-Positive Inpatients With Abnormal Liver Tests

  2022influential citation
• Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency

  2022cites this paper
• Changes in liver function test levels in HIV patients undergoing highly active antiretroviral therapy (HAART). Longitudinal study in Lima, Peru

  2022cites this paper
• In silico, in vitro screening of antioxidant and anticancer potentials of bioactive secondary metabolites from an endophytic fungus (Curvularia sp.) from Phyllanthus niruri L

  2022cites this paper
• Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal

  2022cites this paper
• iDVIP: identification and characterization of viral integrase inhibitory peptides

  2022cites this paper
• Microbial translocation is associated with advanced liver fibrosis among people with HIV

  2022cites this paper
• Diagnosis and Clinical Manifestations of Acute Hepatitis C Infection in People Living with HIV

  2022cites this paper
• Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance

  2022cites this paper
• Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1

  2022cites this paper
• Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation

  2022cites this paper
• Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy

  2022cites this paper
• HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection

  2022cites this paper
• Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children

  2022cites this paper
• A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction

  2022cites this paper
• Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban Population

  2022cites this paper
• Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct‐acting antiviral agents: A national inpatient sample study

  2022cites this paper
• Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection

  2021cites this paper
• Treatment of HCV, HDV, or HIV Coinfections

  2021cites this paper
• HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases

  2021cites this paper
• Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging.

  2021cites this paper
• Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?

  2021cites this paper
• Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients

  2021cites this paper
• Effects of HIV-1 Proteins, Mechanisms Behind.

  2021cites this paper
• Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?

  2021cites this paper
• Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study

  2021cites this paper
• Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind

  2021cites this paper
• Lack of association between recent cannabis use and advanced liver fibrosis among HIV-positive heavy drinkers.

  2021cites this paper
• AWARENESS OF STRUCTURAL BIOLOGY OF HIV AMONG DENTAL STUDENTS

  2021cites this paper
• Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults

  2021cites this paper
• Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research

  2021cites this paper
• Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma

  2021cites this paper
• 敗血症を繰り返したHCV・HBV・HIV共感染肝硬変の一例

  2020cites this paper
• Causative factors of liver fibrosis in HIV-infected patients. A single center study

  2020cites this paper
• Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection

  2020cites this paper
• Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa.

  2020cites this paper
• Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

  2020cites this paper
• Cocaine Use: A Threat for the HIV-Infected Liver

  2020cites this paper
• Barriers to uptake of hepatitis C virus (HCV) health intervention among men who have sex with men in Southwest China: A qualitative study.

  2020cites this paper
• A case of complicated recurrent sepsis with liver cirrhosis due to HCV, HBV, and HIV coinfection

  2020cites this paper
• Diseases of the Liver

  2020cites this paper
• HIV host genomics in the era of effective antiretroviral therapy

  2020cites this paper
• SYSTEMIC TREATMENT OF HCC IN SPECIAL POPULATIONS.

  2020cites this paper
• Prevalence and Factors Associated with Hepatic Steatosis and Fibrosis Using Fibroscan in HIV-positive Patients Treated with Anti-retroviral (ARV) Medicines Referred to the Biggest Hospital in Tehran, 2018 to 2019

  2020cites this paper
• The Specifics of the Stromal and Parenchymal Liver Components of 0–6-month-old Dead Children from HIV-monoinfected Mothers

  2020cites this paper
• Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV.

  2020cites this paper
• Polypharmacy and frailty among persons with HIV

  2020cites this paper
• Outcomes of donor-derived superinfection screening in HIV-positive to HIV-positive kidney and liver transplantation: a multicentre, prospective, observational study.

  2020cites this paper
• Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection.

  2020cites this paper
• Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice

  2020cites this paper
• Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients.

  2019cites this paper
• Seroprevalence of HBsAg among HIV Infected Sudanese Patient in Khartoum State

  2019cites this paper
• Eliminating hepatitis C in the UK among men who have sex with men during the era of pre-exposure prophylaxis

  2019cites this paper
• Severe Liver Fibrosis and Association with Plasma Inflammatory Biomarkers among HIV/HCV Co-infected Patients in China :a Cross-Sectional Study

  2019cites this paper
• CXCL12 G801A polymorphism is associated with significant liver fibrosis in HIV-infected Thais: a cross-sectional study.

  2019cites this paper
• Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

  2019cites this paper
• Sunscreen ingredients in plasma: a threat for drug–drug interactions and toxicity among patients living with HIV?

  2019cites this paper
• Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)

  2019cites this paper
• AIDS-Related Gastrointestinal Cancers

  2019cites this paper
• Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.

  2019cites this paper